Enzo Biochem
ENZ
$1.06
Share price
0.00%
Change (1 day)
-58.27%
Change (1 year)
Categories
Operating Margin for Enzo Biochem (ENZ)
Operating Margin as of April 2024 (TTM): -43.44%
According to Enzo Biochem's latest financial reports and stock price the company's current Operating Margin is -43.44%. At the end of 2022 the company had an Operating Margin of -17.06%.
Operating Margin history for Enzo Biochem from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -17.06% | -354.97% |
| 2021 | 6.69% | -117.83% |
| 2020 | -37.52% | -1323.45% |
| 2019 | 3.07% | -128.12% |
| 2018 | -10.90% | 385.34% |
| 2017 | -2.25% | -104.96% |
| 2016 | 45.26% | -2027.28% |
| 2015 | -2.35% | -77.25% |
| 2014 | -10.32% | -48.95% |
| 2013 | -20.22% | -49.06% |
| 2012 | -39.70% | 215.86% |
| 2011 | -12.57% | -45.19% |
| 2010 | -22.93% | -12.51% |
| 2009 | -26.21% | 87.2% |
| 2008 | -14.00% | -43.78% |
| 2007 | -24.90% | -41.69% |
| 2006 | -42.71% | -455.29% |
| 2005 | 12.02% | -145.18% |
| 2004 | -26.61% | -345.21% |
| 2003 | 10.85% | -43.32% |
| 2002 | 19.14% | -8.59% |
| 2001 | 20.94% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | 11.10% | -125.55% | 🇺🇸 USA |
 LabCorp LH | 10.63% | -124.47% | 🇺🇸 USA |
 RadNet RDNT | 3.00% | -106.91% | 🇺🇸 USA |
 Psychemedics PMD | -4.12% | -90.52% | 🇺🇸 USA |
 NeoGenomics
NEO | -31.26% | -28.04% | 🇺🇸 USA |
 Qiagen QGEN | 23.93% | -155.09% | 🇳🇱 Netherlands |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.